Laurus Labs agrees to acquire stake in Phekolong Pharmaceuticals

19 Sep 2019 Evaluate

Laurus Labs has agreed to acquire 100% shares of Phekolong Pharmaceuticals, a wholly owned subsidiary company of Pharmacare t/a Aspen Pharmacare, South Africa, subject to completion of conditions precedent, by way of cash consideration of South African Rand (ZAR) 75,000.

This transaction will provide the company access to the South African public antiretroviral (ARV) sector, which manages the world's largest public ARV programme. While Aspen will continue to manufacture the finished dose form ARV's for the South African public sector, the supply to this sector will be through Laurus' newly acquired South African subsidiary.

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Laurus Labs Share Price

610.90 6.70 (1.11%)
21-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1783.90
Dr. Reddys Lab 1199.30
Cipla 1523.30
Lupin 2115.70
Zydus Lifesciences 918.35
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...